Angiotensin-converting enzyme insertion or deletion dimorphism in predisposition to cardiovascular diseases amongst United Arab Emirates nationals

P. M. Frossard, A. M. Bokhari, Y. I. Elshahat, G. G. Lestringant, A. M. John, S. H. Hill, Abdishakur Abdulle, E. N. Obineche

Research output: Contribution to journalArticle

Abstract

Objectives: The absence of a 287 base pairs Alu sequence in the angiotensin-converting enzyme gene (D allele) is associated with higher angiotensin converting enzyme levels than its presence (I allele). There is, however, a huge body of conflicting reports that have linked angiotensin-converting enzyme insertion/deletion to hypertension, ischaemic heart disease, myocardial infarction, left ventricular hypertrophy, as well as several other clinical entities. We carried out a retrospective, case-control study of the angiotensin-converting enzyme insertion/deletion dimorphism in relation to circulating angiotensin-converting enzyme activity, as well as to hypertention, ischemic heart disease, myocardial infaction and left ventricular hypertrophy, amongst United Arab Emirates nationals subjects (Emirati). Methods: We investigated a sample population of 285 Emirati comprising groups of controls and of patients with clinical diagnoses of hypertension, ischaemic heart disease, myocardial infaction and left ventricular hypertrophy. Angiotensin-converting enzyme insertion/deletion genotypes were determined by assays based on polymerase chain reaction. Results: The D allele was associated with increased circulating angiotensin-converting enzyme activity, and the angiotensin-converting enzyme insertion/deletion marker accounted for 28% of the variance of the phenomenon determining angiotensin-converting enzyme levels. We found, however, no association between angiotensin-converting enzyme insertion/deletion and clinical diagnoses of hypertension, ischaemic heart disease, myocardial infarction and left ventricular hypertrophy. Conclusion: Although the D allele of the angiotensin converting enzyme insertion/deletion dimorphism tracks with circulating angiotensin-converting enzyme activities in United Arab Emirates nationals, it does not constitute a predictive marker for CVDs in this population.

Original languageEnglish (US)
Pages (from-to)713-719
Number of pages7
JournalSaudi Medical Journal
Volume19
Issue number6
StatePublished - Dec 1 1998

Fingerprint

United Arab Emirates
Peptidyl-Dipeptidase A
Cardiovascular Diseases
Left Ventricular Hypertrophy
Myocardial Ischemia
Alleles
Hypertension
Myocardial Infarction
Base Pairing
Population
Case-Control Studies

Keywords

  • Angiotensin-converting enzyme
  • Cardiovascular diseases
  • Genetics
  • Hypertension
  • Myocardial infarction
  • Polymerase chain reaction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Frossard, P. M., Bokhari, A. M., Elshahat, Y. I., Lestringant, G. G., John, A. M., Hill, S. H., ... Obineche, E. N. (1998). Angiotensin-converting enzyme insertion or deletion dimorphism in predisposition to cardiovascular diseases amongst United Arab Emirates nationals. Saudi Medical Journal, 19(6), 713-719.

Angiotensin-converting enzyme insertion or deletion dimorphism in predisposition to cardiovascular diseases amongst United Arab Emirates nationals. / Frossard, P. M.; Bokhari, A. M.; Elshahat, Y. I.; Lestringant, G. G.; John, A. M.; Hill, S. H.; Abdulle, Abdishakur; Obineche, E. N.

In: Saudi Medical Journal, Vol. 19, No. 6, 01.12.1998, p. 713-719.

Research output: Contribution to journalArticle

Frossard, PM, Bokhari, AM, Elshahat, YI, Lestringant, GG, John, AM, Hill, SH, Abdulle, A & Obineche, EN 1998, 'Angiotensin-converting enzyme insertion or deletion dimorphism in predisposition to cardiovascular diseases amongst United Arab Emirates nationals', Saudi Medical Journal, vol. 19, no. 6, pp. 713-719.
Frossard, P. M. ; Bokhari, A. M. ; Elshahat, Y. I. ; Lestringant, G. G. ; John, A. M. ; Hill, S. H. ; Abdulle, Abdishakur ; Obineche, E. N. / Angiotensin-converting enzyme insertion or deletion dimorphism in predisposition to cardiovascular diseases amongst United Arab Emirates nationals. In: Saudi Medical Journal. 1998 ; Vol. 19, No. 6. pp. 713-719.
@article{edf9f79d401d4db58c9ac9f57c05dbe5,
title = "Angiotensin-converting enzyme insertion or deletion dimorphism in predisposition to cardiovascular diseases amongst United Arab Emirates nationals",
abstract = "Objectives: The absence of a 287 base pairs Alu sequence in the angiotensin-converting enzyme gene (D allele) is associated with higher angiotensin converting enzyme levels than its presence (I allele). There is, however, a huge body of conflicting reports that have linked angiotensin-converting enzyme insertion/deletion to hypertension, ischaemic heart disease, myocardial infarction, left ventricular hypertrophy, as well as several other clinical entities. We carried out a retrospective, case-control study of the angiotensin-converting enzyme insertion/deletion dimorphism in relation to circulating angiotensin-converting enzyme activity, as well as to hypertention, ischemic heart disease, myocardial infaction and left ventricular hypertrophy, amongst United Arab Emirates nationals subjects (Emirati). Methods: We investigated a sample population of 285 Emirati comprising groups of controls and of patients with clinical diagnoses of hypertension, ischaemic heart disease, myocardial infaction and left ventricular hypertrophy. Angiotensin-converting enzyme insertion/deletion genotypes were determined by assays based on polymerase chain reaction. Results: The D allele was associated with increased circulating angiotensin-converting enzyme activity, and the angiotensin-converting enzyme insertion/deletion marker accounted for 28{\%} of the variance of the phenomenon determining angiotensin-converting enzyme levels. We found, however, no association between angiotensin-converting enzyme insertion/deletion and clinical diagnoses of hypertension, ischaemic heart disease, myocardial infarction and left ventricular hypertrophy. Conclusion: Although the D allele of the angiotensin converting enzyme insertion/deletion dimorphism tracks with circulating angiotensin-converting enzyme activities in United Arab Emirates nationals, it does not constitute a predictive marker for CVDs in this population.",
keywords = "Angiotensin-converting enzyme, Cardiovascular diseases, Genetics, Hypertension, Myocardial infarction, Polymerase chain reaction",
author = "Frossard, {P. M.} and Bokhari, {A. M.} and Elshahat, {Y. I.} and Lestringant, {G. G.} and John, {A. M.} and Hill, {S. H.} and Abdishakur Abdulle and Obineche, {E. N.}",
year = "1998",
month = "12",
day = "1",
language = "English (US)",
volume = "19",
pages = "713--719",
journal = "Saudi Medical Journal",
issn = "0379-5284",
publisher = "Saudi Arabian Armed Forces Hospital",
number = "6",

}

TY - JOUR

T1 - Angiotensin-converting enzyme insertion or deletion dimorphism in predisposition to cardiovascular diseases amongst United Arab Emirates nationals

AU - Frossard, P. M.

AU - Bokhari, A. M.

AU - Elshahat, Y. I.

AU - Lestringant, G. G.

AU - John, A. M.

AU - Hill, S. H.

AU - Abdulle, Abdishakur

AU - Obineche, E. N.

PY - 1998/12/1

Y1 - 1998/12/1

N2 - Objectives: The absence of a 287 base pairs Alu sequence in the angiotensin-converting enzyme gene (D allele) is associated with higher angiotensin converting enzyme levels than its presence (I allele). There is, however, a huge body of conflicting reports that have linked angiotensin-converting enzyme insertion/deletion to hypertension, ischaemic heart disease, myocardial infarction, left ventricular hypertrophy, as well as several other clinical entities. We carried out a retrospective, case-control study of the angiotensin-converting enzyme insertion/deletion dimorphism in relation to circulating angiotensin-converting enzyme activity, as well as to hypertention, ischemic heart disease, myocardial infaction and left ventricular hypertrophy, amongst United Arab Emirates nationals subjects (Emirati). Methods: We investigated a sample population of 285 Emirati comprising groups of controls and of patients with clinical diagnoses of hypertension, ischaemic heart disease, myocardial infaction and left ventricular hypertrophy. Angiotensin-converting enzyme insertion/deletion genotypes were determined by assays based on polymerase chain reaction. Results: The D allele was associated with increased circulating angiotensin-converting enzyme activity, and the angiotensin-converting enzyme insertion/deletion marker accounted for 28% of the variance of the phenomenon determining angiotensin-converting enzyme levels. We found, however, no association between angiotensin-converting enzyme insertion/deletion and clinical diagnoses of hypertension, ischaemic heart disease, myocardial infarction and left ventricular hypertrophy. Conclusion: Although the D allele of the angiotensin converting enzyme insertion/deletion dimorphism tracks with circulating angiotensin-converting enzyme activities in United Arab Emirates nationals, it does not constitute a predictive marker for CVDs in this population.

AB - Objectives: The absence of a 287 base pairs Alu sequence in the angiotensin-converting enzyme gene (D allele) is associated with higher angiotensin converting enzyme levels than its presence (I allele). There is, however, a huge body of conflicting reports that have linked angiotensin-converting enzyme insertion/deletion to hypertension, ischaemic heart disease, myocardial infarction, left ventricular hypertrophy, as well as several other clinical entities. We carried out a retrospective, case-control study of the angiotensin-converting enzyme insertion/deletion dimorphism in relation to circulating angiotensin-converting enzyme activity, as well as to hypertention, ischemic heart disease, myocardial infaction and left ventricular hypertrophy, amongst United Arab Emirates nationals subjects (Emirati). Methods: We investigated a sample population of 285 Emirati comprising groups of controls and of patients with clinical diagnoses of hypertension, ischaemic heart disease, myocardial infaction and left ventricular hypertrophy. Angiotensin-converting enzyme insertion/deletion genotypes were determined by assays based on polymerase chain reaction. Results: The D allele was associated with increased circulating angiotensin-converting enzyme activity, and the angiotensin-converting enzyme insertion/deletion marker accounted for 28% of the variance of the phenomenon determining angiotensin-converting enzyme levels. We found, however, no association between angiotensin-converting enzyme insertion/deletion and clinical diagnoses of hypertension, ischaemic heart disease, myocardial infarction and left ventricular hypertrophy. Conclusion: Although the D allele of the angiotensin converting enzyme insertion/deletion dimorphism tracks with circulating angiotensin-converting enzyme activities in United Arab Emirates nationals, it does not constitute a predictive marker for CVDs in this population.

KW - Angiotensin-converting enzyme

KW - Cardiovascular diseases

KW - Genetics

KW - Hypertension

KW - Myocardial infarction

KW - Polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=2442615017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442615017&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:2442615017

VL - 19

SP - 713

EP - 719

JO - Saudi Medical Journal

JF - Saudi Medical Journal

SN - 0379-5284

IS - 6

ER -